PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 30, 2026Polymer Engineering and Science0 citations

Fabrication of Hydrophobic Laponite Nanoclay‐Loaded Polycaprolactone Electrospun Membranes for Hemostatic Applications

View Full Paper
TVThong Lam VuTTThi-Kieu-Anh TranKLKhoi Minh Le

Key Points

  • The study aims to create and assess the properties of hydrophobic electrospun membranes for hemostatic applications.
  • Fabrication of membranes using polycaprolactone and varied concentrations of laponite nanoclay
  • Morphological, physical, chemical, and biological property testing of membranes
  • In vitro and in vivo hemostatic tests were conducted to evaluate effectiveness.
  • Membrane strength increased by 1.36 times with laponite compared to PCL alone
  • 40% laponite concentration exhibited optimal blood clotting time and reduced blood loss in the liver incision model
  • No toxic or hemolytic responses noted in cytotoxicity and hemolysis tests.

Abstract

ABSTRACT Death caused by uncontrolled bleeding is one of the most common causes worldwide, particularly in traffic accidents and surgical emergencies. Hence, hemostatic materials play a pivotal role in preventing such fatalities by rapidly promoting blood clotting and stabilizing the injury site that could save patient lives. In this study, our aim is to fabricate and characterize a hydrophobic hemostatic electrospun membrane based on polycaprolactone (PCL) integrated with different concentrations of laponite nanoclay (LAP). Multiple properties are tested, including morphological, physical, chemical, and biological properties. The fabricated membranes have a fiber size from 100 to 500 nm and a hydrophobic property with a water contact angle above 135°. The membrane strength is enhanced with a small amount of laponite, by 1.36 times compared to the PCL membrane without nanoclay. Furthermore, LAP concentrations of 20% and 40% demonstrate significant efficiency in in vitro hemostatic tests compared to other LAP membranes. In vivo hemostatic experiments with the liver incision model demonstrate that the blood clotting time and blood loss of the 40% LAP added PCL membrane are 70.67 ± 17.21 s and 4.70 ± 1.79 mg g −1 , respectively. All the fabricated membranes have not caused toxic and hemolytic activities in cytotoxic and hemolysis experiments. The results indicate that LAP@PCL membranes have great potential in hemostatic applications as hydrophobic membranes.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Vu et al. (2026) studied this question.

synapsesocial.com/papers/69c9c51bf8fdd13afe0bd1cdhttps://doi.org/10.1002/pen.70489
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Fabrication and Characterization of Fe-Mg/HAP-Loaded PCL/PEG Nanofibrous Membranes for Improved Wound Healing2025
  2. 2Fabrication and characterization of starch/polycaprolactone nanofibers loaded with tranexamic acid as a hemostatic agent under in vitro2026
  3. 3Electrospun poly(ɛ‐caprolactone) membranes modified with heparin and essential fatty acids for biomedical applications2024
  4. 4Electrospun Poly (ε-caprolactone) Membranes Modified with Heparin and Essential Fatty Acids for Biomedical Applications2024
  5. 5Fabrication and Characterization of <scp>PVP</scp> / <scp>PCL</scp> Nanofiber‐Hydrogel Membranes via Juxtaposed Electrospinning for Wound Dressings2026 · 3 citations